Q-omics provides the consensus-scored TRMT112P1 profile across patient tissues and cancer cell-line models. TRMT112P1 expression is associated with patient survival in 12 of 34 cancer types, with the highest sampling consensus in KIRC. Additionally, TRMT112P1 RNA expression shows 10,631 significant gene co-expression associations, with the highest sampling consensus in THYM. Together, these results highlight KIRC, and THYM as cancer lineages where TRMT112P1 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.